Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Translating medical evidence to promote informed health care decisions.

McCormack L, Treiman K, Bann C, Williams-Piehota P, Driscoll D, Poehlman J, Soloe C, Lohr K, Sheridan S, Golin C, Cykert S, Harris R.

Health Serv Res. 2011 Aug;46(4):1200-23. doi: 10.1111/j.1475-6773.2011.01248.x. Epub 2011 Feb 25.

2.

A community-based intervention to promote informed decision making for prostate cancer screening among Hispanic American men changed knowledge and role preferences: a cluster RCT.

Chan EC, McFall SL, Byrd TL, Mullen PD, Volk RJ, Ureda J, Calderon-Mora J, Morales P, Valdes A, Kay Bartholomew L.

Patient Educ Couns. 2011 Aug;84(2):e44-51. doi: 10.1016/j.pec.2010.07.033. Epub 2011 Jan 14.

PMID:
21237611
3.

Behind Closed Doors: What Happens when Patients and Providers Talk about Prostate-Specific Antigen Screening?: Survey of the Effects of a Community-Based Intervention.

McCormack L, Williams-Piehota P, Bann C.

Patient. 2009 Sep 1;2(3):191-201. doi: 10.2165/11312730-000000000-00000.

PMID:
22273170
4.

Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?

O'Dell KJ, Volk RJ, Cass AR, Spann SJ.

J Fam Pract. 1999 Sep;48(9):682-8.

PMID:
10498074
5.

Promoting prostate-specific antigen informed decision-making. Evaluating two community-level interventions.

Driscoll DL, Rupert DJ, Golin CE, McCormack LA, Sheridan SL, Welch BM, Poehlman JA.

Am J Prev Med. 2008 Aug;35(2):87-94. doi: 10.1016/j.amepre.2008.04.016.

PMID:
18617077
6.

Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.

Watson E, Hewitson P, Brett J, Bukach C, Evans R, Edwards A, Elwyn G, Cargill A, Austoker J.

Patient Educ Couns. 2006 Nov;63(3):367-79. Epub 2006 Jul 27.

PMID:
16875796
7.

Health information styles among participants in a prostate cancer screening informed decision-making intervention.

Williams-Piehota PA, McCormack LA, Treiman K, Bann CM.

Health Educ Res. 2008 Jun;23(3):440-53. doi: 10.1093/her/cyn011. Epub 2008 Apr 2.

PMID:
18385197
8.

Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study).

Hoffman RM, Couper MP, Zikmund-Fisher BJ, Levin CA, McNaughton-Collins M, Helitzer DL, VanHoewyk J, Barry MJ.

Arch Intern Med. 2009 Sep 28;169(17):1611-8. doi: 10.1001/archinternmed.2009.262.

PMID:
19786681
9.

A randomized controlled trial of shared decision making for prostate cancer screening.

Volk RJ, Cass AR, Spann SJ.

Arch Fam Med. 1999 Jul-Aug;8(4):333-40.

PMID:
10418541
10.

The impact of informed consent on patient interest in prostate-specific antigen screening.

Wolf AM, Nasser JF, Wolf AM, Schorling JB.

Arch Intern Med. 1996 Jun 24;156(12):1333-6.

PMID:
8651843
11.

Informed decision making on PSA testing for the detection of prostate cancer: an evaluation of a leaflet with risk indicator.

van Vugt HA, Roobol MJ, Venderbos LD, Joosten-van Zwanenburg E, Essink-Bot ML, Steyerberg EW, Bangma CH, Korfage IJ.

Eur J Cancer. 2010 Feb;46(3):669-77. doi: 10.1016/j.ejca.2009.11.022.

PMID:
20022239
12.

Does 'peer coaching' increase GP capacity to promote informed decision making about PSA screening? A cluster randomised trial.

Gattellari M, Donnelly N, Taylor N, Meerkin M, Hirst G, Ward JE.

Fam Pract. 2005 Jun;22(3):253-65. Epub 2005 Apr 11. Erratum in: Fam Pract. 2009 Aug;26(4):335.

PMID:
15824055
13.

Deliberative democracy and cancer screening consent: a randomised control trial of the effect of a community jury on men's knowledge about and intentions to participate in PSA screening.

Thomas R, Glasziou P, Rychetnik L, Mackenzie G, Gardiner R, Doust J.

BMJ Open. 2014 Dec 24;4(12):e005691. doi: 10.1136/bmjopen-2014-005691.

14.

Shared decision making for prostate cancer screening: the results of a combined analysis of two practice-based randomized controlled trials.

Sheridan SL, Golin C, Bunton A, Lykes JB, Schwartz B, McCormack L, Driscoll D, Bangdiwala SI, Harris RP.

BMC Med Inform Decis Mak. 2012 Nov 13;12:130. doi: 10.1186/1472-6947-12-130.

15.
16.

Classifying the reasons men consider to be important in prostate-specific antigen (PSA) testing decisions: evaluating risks, lay beliefs, and informed decisions.

McDowell ME, Occhipinti S, Chambers SK.

Ann Behav Med. 2013 Dec;46(3):322-35. doi: 10.1007/s12160-013-9508-4.

PMID:
23653418
17.

Unwanted control: how patients in the primary care setting decide about screening for prostate cancer.

Woolf SH, Krist AH, Johnson RE, Stenborg PS.

Patient Educ Couns. 2005 Jan;56(1):116-24.

PMID:
15590232
18.

Informed decision making: what is its role in cancer screening?

Rimer BK, Briss PA, Zeller PK, Chan EC, Woolf SH.

Cancer. 2004 Sep 1;101(5 Suppl):1214-28. Review.

19.

Shared decision making in prostate-specific antigen testing: the effect of a mailed patient flyer prior to an annual exam.

Landrey AR, Matlock DD, Andrews L, Bronsert M, Denberg T.

J Prim Care Community Health. 2013 Jan;4(1):67-74. doi: 10.1177/2150131912447074. Epub 2012 May 16.

PMID:
23799692
20.

Applying strategies from libertarian paternalism to decision making for prostate specific antigen (PSA) screening.

Wheeler DC, Szymanski KM, Black A, Nelson DE.

BMC Cancer. 2011 Apr 21;11:148. doi: 10.1186/1471-2407-11-148.

Supplemental Content

Support Center